Anteris Technologies Global Corp Receivables Turnover Ratio (AVR), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Anteris Technologies Global Corp   (AVR)
 

Anteris Technologies Global Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Anteris Technologies Global Corp 's ability to collect accounts receivable sequentially worsen to 5.06, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Anteris Technologies Global 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 72 days, from 68 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 518 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from to 3581.

What is Receivable Turnover Ratio?
What is Anteris Technologies Global Corp Selling?


What is Receivable Turnover Ratio?





AVR Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change 22.22 % -55.38 % - - -
Y / Y Revenue Change -11.15 % -42.16 % -44.21 % -2.22 % -27.42 %
Receivable Turnover Ratio (TTM) 5.06 5.38 4.73 6.3 11.26
AVR's Total Ranking # 3581 # # # #
Accounts Receivable average collection period days 72 68 77 58 32
Seq. Receivable Change -25.72 % 32.91 % -65.94 % 263.49 % -72.88 %
Seq. Revenue Change 59.35 % -27.74 % -30.58 % 11.15 % 3.73 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 170
Healthcare Sector # 519
Overall Market # 3581

Receivable Turnover Ratio Statistics
High Average Low
0.05 0.04 0.02
(Dec 31 2025)   (Mar 31 2026)






Financial Statements
Anteris Technologies Global 's Accounts Receivable $ 0 Millions Visit AVR's Balance sheet
Anteris Technologies Global 's Sales TTM $ 2 Millions Visit AVR's Income Statement
Sources of AVR's Revenues Visit AVR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVR's Growth Rates AVR's Roa AVR's Inventory Turnover Ratio AVR's Dividend Comparisons
AVR's Profitability Ratios AVR's Roi AVR's Asset Turnover Ratio AVR's Dividend Growth
AVR's Valuation Ratios AVR's Roe AVR's Financial Strength Ratios AVR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Fonar Corporation  21.15 $ 105.338  Millions$ 4.981  Millions
Neuraxis Inc   20.94 $ 4.282  Millions$ 0.204  Millions
Vystar Corporation  20.58 $ 0.048  Millions$ 0.002  Millions
Lifemd Inc   19.91 $ 177.869  Millions$ 8.934  Millions
Longeveron Inc   19.07 $ 1.216  Millions$ 0.064  Millions
Sonida Senior Living Inc   18.82 $ 411.850  Millions$ 21.878  Millions
Nutriband Inc   16.79 $ 1.803  Millions$ 0.107  Millions
Bioadaptives Inc   16.64 $ 0.024  Millions$ 0.001  Millions
Premier Air Charter Holdings Inc   16.33 $ 33.205  Millions$ 2.033  Millions
Bioage Labs Inc   15.90 $ 10.316  Millions$ 0.649  Millions
Escalon Medical Corp   15.15 $ 11.445  Millions$ 0.756  Millions
Nurix Therapeutics Inc   15.11 $ 71.779  Millions$ 4.750  Millions
Rosecliff Acquisition Corp I  15.05 $ 23.433  Millions$ 1.557  Millions
Lexicon Pharmaceuticals Inc   14.91 $ 69.643  Millions$ 4.670  Millions
Qhslab Inc   14.80 $ 2.775  Millions$ 0.188  Millions
Nexgel Inc   14.19 $ 10.382  Millions$ 0.732  Millions
Sutro Biopharma Inc   14.04 $ 99.608  Millions$ 7.095  Millions
Precipio inc   13.93 $ 25.831  Millions$ 1.854  Millions
China Pharma Holdings Inc  13.86 $ 3.992  Millions$ 0.288  Millions
Talkspace Inc   13.67 $ 239.269  Millions$ 17.501  Millions
Marpai Inc  13.59 $ 17.125  Millions$ 1.261  Millions
Amneal Pharmaceuticals Inc   13.56 $ 3,045.530  Millions$ 224.634  Millions
Corcept Therapeutics Inc  13.20 $ 769.096  Millions$ 58.264  Millions
Xoma Royalty Corporation  13.05 $ 48.555  Millions$ 3.720  Millions
Mannkind Corporation  13.00 $ 360.783  Millions$ 27.757  Millions
Lifestance Health Group Inc   12.74 $ 1,494.791  Millions$ 117.296  Millions
Chemed Corporation  12.73 $ 2,540.548  Millions$ 199.626  Millions
Milestone Scientific Inc   12.69 $ 8.337  Millions$ 0.657  Millions
Lftd Partners Inc   12.55 $ 36.955  Millions$ 2.945  Millions
Clene Inc   12.47 $ 0.134  Millions$ 0.011  Millions

Date modified: 2026-08-30T15:07:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.